Company Name
2Seventy Bio Inc
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
ISIN:
US9013841070
CIK:
0001860782
CUSIP:
901384107
Currency:
USD
Full Time Employees:
65
Phone:
617 675 7270
Website:
https://www.2seventybio.com
Fiscal Year End:
December
IPO Date:
Nov 03, 2021
Description:
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. The company's products pipeline includes Abecma, a chimeric antigen receptor T-cell product candidates for the treatment of multiple myeloma. It has a collaboration arrangement with Bristol Myers Squibb Company. 2seventy bio, Inc. was incorporated in 2021 and is headquartered in Cambridge, Massachusetts.
Address:
60 Binney Street, Cambridge, MA, United States, 02142